Three things to know about FDA-authorized trials
A quick explainer on how FDA-authorized clinical trials work.
About
About Zhittya Genesis Medicine
Zhittya Genesis Medicine is a clinical-stage biotechnology company in Las Vegas, Nevada. It is developing FGF-1, an investigational protein.
Who we are
Zhittya Genesis Medicine studies FGF-1, a protein the body makes naturally that signals the growth of new small blood vessels. The people who lead the company have worked on FGF-1 since 1998.
Since May 2022, Zhittya has been studying FGF-1 in people living with Parkinson's. It makes the FGF-1 used in its research at its lab in Reno, Nevada.
Brain imaging in this research is done at Washington University in St. Louis. The first result is in the data section of the research page.
The team
Dan Montano
Chief Executive Officer
Dan spent 30 years in investment banking, where he helped start close to 100 companies built around new technologies. He left finance in 1998 to work on biotechnology full time. He holds an MBA from the University of Southern California.
Dr. Jack Jacobs
President and Chief Science Officer
Dr. Jacobs has worked in drug development for more than 25 years, including starting a biological chemistry department at Merck. Earlier in his career he oversaw FDA-authorized clinical trials of FGF-1 in coronary artery disease, diabetic foot ulcers and peripheral artery disease. He holds a PhD in molecular biology from Washington University in St. Louis.
Viktoriya Tamlenova-Montano
Executive Vice President
Viktoriya has worked in biotechnology for more than 20 years, including technology transfer from Ukraine to the United States, clinical trial development and research into new uses of angiogenesis medicines. She speaks six languages.
Judith Luell
Vice President of Operations
Judy joined Dan Montano in 2004, when FGF-1 was being studied in severe heart disease and diabetic foot ulcers. She manages the contracts, regulatory filings and operations that surround clinical studies.
Jacqueline Arevalo
Clinical Trial Manager
Jacqueline holds a master's degree in biotechnology from the University of Nevada, Reno. Her background is in immunodiagnostics, microbiology and analytical chemistry in regulated laboratories.
Tezo Albarran-Martinez
Research Scientist II
Tezo holds bachelor's and master's degrees in biotechnology from the University of Nevada, Reno. He has worked in protein expression and purification, genomics, and patient care.
Emily Vazquez
Research Scientist I
Emily holds a master's degree in biotechnology and a bachelor's degree in biochemistry and molecular biology from the University of Nevada, Reno. Her research experience spans molecular biology, reproductive physiology and cancer biology.
Owen Boxx
Business Information Specialist
Owen holds a bachelor's degree in computer science and engineering from the University of Nevada, Reno. He has built software since high school, including a prototype biometric lock designed to reduce opioid diversion in pharmacies.
Khiry Anderson
Vice President of Business Operations
Khiry brings experience in management, marketing and software to Zhittya's operations and outreach.
Daniel H. Montano
Vice President of Drug Development
Daniel has worked in biotechnology for 10 years and assists with the manufacturing of FGF-1.
Sergiy Montano
Vice President of Marketing
Sergiy leads Zhittya's marketing and has worked across the company since 2017. He holds a degree in business administration from the University of California, Irvine, and studied at the Universitat de Barcelona. He speaks English, Spanish and Russian.
Inside the lab
Short clips from the lab in Reno, Nevada: how FGF-1 is made, and the people who make it. Newest first.
Videos play here on this page. Press Play to bring up the video, then press the red YouTube button to start it. Captions are turned on when the video has them.
Ask the lab team
The lab team answers a question about their work.
Inside the Reno lab with Dr. Jack Jacobs
A walk through the lab where Zhittya makes FGF-1.
Preparing growth media with Megan
Megan mixes the nutrient broth that feeds the bacteria used to produce FGF-1.
Behind the scenes with Megan
One of Zhittya's scientists shows a day of work at the bench.
Purifying the protein
A look at the chromatography step that separates FGF-1 from everything else.
The small tools that keep a lab running
Pipettes, flasks and the everyday equipment behind the research.
From a test tube to nine liters
How a small starter culture grows into a full production batch.
Contact
Phone
(702) 790-9980
Email
sergiy@zhittyamedicine.com
Mail
Zhittya Genesis Medicine
8683 West Sahara Avenue, Suite 280
Las Vegas, Nevada 89117
United States
Text messages about the interest list come from (866) 786-0044. Reply STOP to that number at any time to stop them.
To see, correct or delete the information you gave us, write to sergiy@zhittyamedicine.com. The privacy policy explains your choices.
Zhittya cannot give medical advice. For a medical question, talk with a doctor. In an emergency, call 911 or the local emergency number.
Want to hear about planned Parkinson's clinical trials?
Zhittya Genesis Medicine keeps an interest list for its planned clinical trials and its medical research studies. Joining is free and does not commit anyone to anything. A caregiver or family member can sign up for someone else.